Tardive dyskinesia: review of treatments past, present, and future.

作者: Prakash S. Masand , Sarah Berry , Donald W. Black , Sanjay Gupta , Diane Mosnik

DOI: 10.1023/A:1022369614773

关键词:

摘要: The aim of this article is to review the theories purported explain pathophysiology tardive dyskinesia (TD) and various agents investigated for its treatment. methods used included a studies in English, Medline search, as well check references listed at end articles was conducted obtain relevant review. results show that vitamin E appears be promising agent both treatment prophylaxis TD. Complete remission has been reported with clozapine, but there need further studies. There are cases benefits numerous miscellaneous agents, including electroconvulsive therapy, no well-designed, substantiating We conclude universally effective Vitamin possibly Clozapine therapy should considered patients refractory traditional antipsychotics who develop Judicious use periodic monitoring remain cornerstone therapy. None atypical (risperidone, olanzapine, quetiapine) have long enough or adequately studied their effects on

参考文章(103)
E Peselow, B Angrist, L Adler, J Rotrosen, S Reiter, Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients. The Journal of Clinical Psychiatry. ,vol. 50, pp. 26- 27 ,(1989)
A W Brotman, J D Wojcik, W E Falk, L Leahy, A J Gelenberg, D J Dorer, A crossover study of lecithin treatment of tardive dyskinesia. The Journal of Clinical Psychiatry. ,vol. 51, pp. 149- 153 ,(1990)
J. O'Brien, R. Barber, Marked improvement in tardive dyskinesia following treatment with olanzapine in an elderly subject. British Journal of Psychiatry. ,vol. 172, pp. 186- 186 ,(1998) , 10.1192/BJP.172.2.186A
Charles M Beasley Jr, Gary Tollefson, Pierre Tran, Winston Satterlee, Todd Sanger, Susan Hamilton, Olanzapine HGAD Study Group, Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial Neuropsychopharmacology. ,vol. 14, pp. 111- 123 ,(1996) , 10.1016/0893-133X(95)00069-P
Vitamin E treatment of tardive dyskinesia. American Journal of Psychiatry. ,vol. 150, pp. 1405- 1407 ,(1993) , 10.1176/AJP.150.9.1405
Herbert Y. Meltzer, Clozapine: Mechanism of Action in Relation to its Clinical Advantages Springer, New York, NY. pp. 237- 256 ,(1990) , 10.1007/978-1-4612-3248-3_11
Effectiveness of verapamil in the treatment of a manic patient. American Journal of Psychiatry. ,vol. 139, pp. 502- ,(1982) , 10.1176/AJP.139.4.502
Daniel D. Sewell, Blain H. Yoshinobu, Michael P. Caligiuri, Dilip V. Jeste, Metoclopramide-associated tardive dyskinesia in hemodialysis patients with diabetes mellitus General Hospital Psychiatry. ,vol. 14, pp. 416- 419 ,(1992) , 10.1016/0163-8343(92)90009-Y